BullishAgent BullishAgent Filings Economic Earnings Ratings IPOs Insiders Institutional ETFs Funds Screener
Sign in Register

LQDA

Liquidia Corporation NASDAQ Listed Jul 26, 2018
Healthcare ·Biotechnology ·US · liquidia.com
$42.31
After hrs $42.66 +0.86%
Mkt Cap $3.7B
52w Low $11.85 87.5% of range 52w High $46.67
50d MA $36.89 200d MA $31.23
P/E (TTM) -47.7x
EV/EBITDA -59.7x
P/B 73.3x
Debt/Equity 4.4x
ROE -154.0%
P/FCF -74.2x
RSI (14)
ATR (14)
Beta 0.46
50d MA $36.89
200d MA $31.23
Avg Volume 1.5M
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
SIC Code
2834
CIK (SEC)
Phone
919 328 4400
419 Davis Drive · Morrisville, NC 27560 · US
Data updated apr 25, 2026 7:50pm · Source: massive.com